HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens

被引:1
|
作者
Wong, Emmett Tsz Yeung [1 ,2 ,3 ]
Pochinco, Denise [4 ]
Vathsala, Anantharaman [1 ,2 ]
Koh, Wee Kun [2 ]
Lim, Amy [2 ]
Sran, Hersharan Kaur [1 ,2 ]
D'Costa, Matthew Ross [2 ]
Chang, Zi Yun [2 ]
Nickerson, Peter W. [3 ,4 ,5 ]
Wiebe, Chris [3 ,4 ,5 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Natl Univ Ctr Organ Transplantat, Singapore, Singapore
[3] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[4] Shared Hlth Serv Manitoba, Winnipeg, MB, Canada
[5] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada
关键词
human leukocyte antigen; histocompatibility; molecular mismatch; eplets; kidney transplant; donor-specific antibodies; MEDIATED REJECTION; EPITOPE-MISMATCH; FAILURE; RISK;
D O I
10.3389/fgene.2024.1447141
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Eplet mismatch has been recognized as a more precise strategy for determining HLA compatibility by analyzing donor-recipient HLA differences at the molecular level. However, predicting post-transplant alloimmunity using single-molecule eplet mismatch categories has not been validated in Asian cohorts. We examined a cohort of Southeast Asian kidney transplant recipients (n = 234) to evaluate HLA-DR/DQ eplet mismatch as a predictor of de novo donor-specific antibody (dnDSA) development. HLA-DR/DQ single-molecule eplet mismatch was quantified using HLA Matchmaker, and we utilized previously published HLA-DR/DQ eplet mismatch thresholds to categorize recipients into alloimmune risk groups and evaluate their association with dnDSA development. Recognizing that the predominance of cyclosporine use (71%) may alter published eplet mismatch thresholds derived from a largely tacrolimus-based (87%) cohort, we evaluated cohort-specific thresholds for HLA-DR/DQ single-molecule eplet mismatch categories. Recipient ethnicities included Chinese (65%), Malays (17%), Indians (14%), and others (4%). HLA-DR/DQ dnDSA developed in 29/234 (12%) recipients after a median follow-up of 5.4 years, including against isolated HLA-DR (n = 7), isolated HLA-DQ (n = 11), or both (n = 11). HLA-DR/DQ single-molecule eplet mismatch risk categories correlated with dnDSA-free survival (p = 0.001) with low-risk recipients having a dnDSA prevalence of 1% over 5 years. The cohort-specific alloimmune risk categories improved correlation with HLA-DR/DQ dnDSA-free survival and remained significant after adjusting for calcineurin inhibitor and anti-metabolite immunosuppression (p < 0.001). We validated the performance of single-molecule eplet mismatch categories as a prognostic biomarker for HLA-DR/DQ dnDSA development in a cohort of predominantly Asian kidney transplant recipients after adjusting for different immunosuppression regimens.
引用
收藏
页数:9
相关论文
共 43 条
  • [1] HLA-DR/DQ eplet mismatch predicts risk of de novo donor-specific fi c antibody development in a multi-ethnic Southeast Asian cohort of kidney transplant recipients
    Wong, E.
    Vathsala, A.
    Sran, H.
    D'Costa, M.
    Chang, Z.
    Wiebe, C.
    HUMAN IMMUNOLOGY, 2024, 85
  • [2] Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients
    Olga Charnaya
    June Jones
    Mary Carmelle Philogene
    Po-Yu Chiang
    Dorry L. Segev
    Allan B. Massie
    Jacqueline Garonzik-Wang
    Pediatric Nephrology, 2021, 36 : 3971 - 3979
  • [3] Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients
    Charnaya, Olga
    Jones, June
    Philogene, Mary Carmelle
    Chiang, Po-Yu
    Segev, Dorry L.
    Massie, Allan B.
    Garonzik-Wang, Jacqueline
    PEDIATRIC NEPHROLOGY, 2020, 36 (12) : 3971 - 3979
  • [4] HLA-DQ heterodimer mismatch number is associated with de novo donor-specific antibody development in pediatric kidney transplant recipients
    Sigurjonsdottir, V. K.
    Wang, L.
    Piburn, K.
    Turudi, D.
    Grimm, P.
    Zhang, M. M.
    HUMAN IMMUNOLOGY, 2024, 85 : 95 - 96
  • [5] HLA-DR/DQ Single Molecule Eplet Mismatch and Formation of De Novo Donor-Specific Anti-HLA Antibodies After Kidney Transplantation in Children
    Sigurjonsdottir, Vaka K.
    Piburn, Kim H.
    Grimm, Paul C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 9 - 9
  • [6] HLA-DR/DQ Single Molecule Eplet Mismatch And Formation Of De Novo Donor-Specific Anti-HLA Antibodies After Kidney Transplantation In Children
    Sigurjonsdottir, Vaka
    Piburn, Kim
    Grimm, Paul
    Zhang, Bing M.
    PEDIATRIC TRANSPLANTATION, 2023, 27
  • [7] HLA-DR/DQ Single Molecule Eplet Mismatch and Formation of De Novo Donor-Specific Anti-HLA Antibodies After Kidney Transplantation in Children.
    Sigurjonsdottir, V. K.
    Piburn, K.
    Grimm, P. C.
    Zhang, B. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 380 - 380
  • [8] SINGLE CENTER STUDY OF ANTIGEN AND EPLET MISMATCH LOAD AND DE NOVO HLA-DR DONOR SPECIFIC ANTIBODY DEVELOPMENT
    Schmitz, John L.
    Franz, Brian
    Montgomery, Maureen
    HUMAN IMMUNOLOGY, 2019, 80 : 157 - 157
  • [9] Risk HLA-DQ Heterodimer Mismatch Is Associated with De Novo Donor-Specific Antibodies in Pediatric Kidney Transplant Recipients
    Sigurjonsdottir, Vaka
    Piburn, Kim H.
    Wang, Lin
    Turudic, Daniel
    Grimm, Paul C.
    Tambur, Anat R.
    Zhang, Bing M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [10] Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients
    Kishikawa, H.
    Kinoshita, T.
    Hashimoto, M.
    Fukae, S.
    Taniguchi, A.
    Yamanaka, K.
    Nakagawa, M.
    Nishimura, K.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (08) : 2388 - 2391